VIA Folio Processes Closing for Myomo, the First Exchange-Traded Reg A+ IPO
VIA Folio is pleased to announce that it has processed the closing of Myomo’s Reg A+ IPO, the first of its kind to be traded on a national exchange. Read more >>
VIA Folio is pleased to announce that it has processed the closing of Myomo’s Reg A+ IPO, the first of its kind to be traded on a national exchange. Read more >>
Aircuity released new data showing that its clients in the life sciences industry are achieving record-setting levels of energy…
read moreRegroup Mass Notification, the award-winning leader in emergency and day-to-day communication technology, today announced a joint alliance with Alvarez…
read moreSkyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid…
read moreCorbus Pharmaceuticals Holdings, Inc. announced today that they have entered into a strategic collaboration with Kaken Pharmaceutical Co., Ltd….
read moreCo-founded by William Korinek of Stonington, who spent nearly a decade at Pfizer, Astrocyte Pharmaceuticals expects to launch a…
read moreBoston Harbor Angels, one of the top three elite angels groups in the US, recognized three portfolio companies at…
read moreZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device, is the…
read moreScrible, the super app that streamlines the research and writing process for students and educators, announced today its new…
read moreBoston’s startups and tech companies were busy in September, pulling in collective billions from VCs and other investors. Here’s…
read moreThe local Lions Club has helped Tammie Caldwell see better than she has in 20 years.
Last month, Caldwell received…